<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on TESCOM EUROPE GMBH %26 CO. KG from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated TESCOM EUROPE GMBH %26 CO. KG news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 02:53:37 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=TESCOM+EUROPE+GMBH+%26+CO.+KG" rel="self" type="application/rss+xml" />

	
<item><title>Karl Kolb GmbH &amp; CO. KG and ELWE Technik GmbH Join Forces</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032846&amp;HITNO=0&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032846&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534833530%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032846&amp;HITNO=0&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032846&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534833530%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Chemie.de:</description></item>
<item><title>Kamada Announces Enrollment of First Patient in Its Pivotal Study for Inhaled AAT in Europe</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037052&amp;HITNO=1&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037052&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536879771%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037052&amp;HITNO=1&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037052&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536879771%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PipelineReview:</description></item>
<item><title>Kamada Announces Enrollment of First Patient in Its Pivotal Study for Inhaled AAT in Europe</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032207&amp;HITNO=2&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032207&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534545101%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032207&amp;HITNO=2&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032207&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534545101%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! Canada:</description></item>
<item><title>RFID Cabinet Maker Expands Overseas Production</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036931&amp;HITNO=3&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036931&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536829731%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036931&amp;HITNO=3&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036931&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536829731%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Diagnostic &amp; Invasive Cardiology:</description></item>
<item><title>Dr. Ritsert Pharma GmbH &amp; Co KG-Company Report - new market report released</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4030727&amp;HITNO=4&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4030727&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533795479%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4030727&amp;HITNO=4&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4030727&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533795479%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PR inside:</description></item>
<item><title>Kamada Announces Enrollment of First Patient in Its Pivotal Study for Inhaled AAT in Europe</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4031628&amp;HITNO=5&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4031628&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534280901%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4031628&amp;HITNO=5&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4031628&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534280901%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>Kamada Announces Enrollment of First Patient in Its Pivotal Study for Inhaled AAT in Europe</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029736&amp;HITNO=6&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029736&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533248249%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029736&amp;HITNO=6&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029736&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533248249%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Genetic Engineering News:</description></item>
<item><title>Kamada Announces Enrollment of First Patient in Its Pivotal Study for Inhaled AAT in Europe</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029700&amp;HITNO=7&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029700&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533238252%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029700&amp;HITNO=7&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029700&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533238252%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Genetic Engineering News:</description></item>
<item><title>Temmler Pharma GmbH &amp; Co. KG-Company Report - new market report released</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4015618&amp;HITNO=8&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4015618&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524456498%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4015618&amp;HITNO=8&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4015618&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524456498%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PR inside:</description></item>
<item><title>clinicalprojects international GmbH Announces Further Growth into New Therapeutic and Geographic Areas</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4010542&amp;HITNO=9&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4010542&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522504652%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4010542&amp;HITNO=9&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4010542&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522504652%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>FKuR expands to North America</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4009425&amp;HITNO=10&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4009425&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2521975805%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4009425&amp;HITNO=10&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4009425&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2521975805%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Chemie.de:</description></item>
<item><title>First Deal for Apeiron a Doozy: Getting up to $329M from GSK</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013086&amp;HITNO=11&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013086&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523605415%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013086&amp;HITNO=11&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013086&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523605415%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>BioWorld:</description></item>
<item><title>First Deal for Apeiron a Doozy: Getting up to $329M from GSK</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4009978&amp;HITNO=12&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4009978&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522184318%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4009978&amp;HITNO=12&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4009978&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522184318%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Therapeutics Daily:</description></item>
<item><title>VDMA Photovoltaic Equipment Forum Appoints Steering Committee</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4002223&amp;HITNO=13&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4002223&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2518788377%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4002223&amp;HITNO=13&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4002223&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2518788377%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Contract Pharma:</description></item>
<item><title>ATLAS Biolabs GmbH Joins Roche NimbleGens Certified Service Provider Program for Targeted Enrichment</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4005848&amp;HITNO=14&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4005848&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2520502495%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4005848&amp;HITNO=14&amp;MSIZE=137&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=TESCOM%20EUROPE%20GMBH%20%26%20CO.%20KG&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4005848&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2520502495%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Freshnews.com:</description></item>
</channel></rss>